The Discounted Cash Flow (DCF) valuation of Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811.SS) is 5.40 CNY. With the latest stock price at 10.03 CNY, the upside of Zhejiang Cheng Yi Pharmaceutical Co Ltd based on DCF is -46.2%.
Based on the latest price of 10.03 CNY and our DCF valuation, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811.SS) is a sell. selling 603811.SS stocks now will result in a potential gain of 46.2%.
| Range | Selected | |
| WACC / Discount Rate | 9.2% - 11.3% | 10.3% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 4.27 - 7.40 | 5.40 |
| Upside | -57.4% - -26.2% | -46.2% |